London; Clare

Patent Applications and Registrations

Patent applications and USPTO patent grants for London; Clare.The latest application filed is for "isoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2".

Company Profile

1.24.27

London; Clare - Chatham NJ
LONDON; Clare - US
London; Clare - Chattam NJ
London; Clare - Sawbridgeworth GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 Grant 10,568,876 - Imbriglio , et al. Feb	2020-02-25
Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 Grant 9,877,957 - Imbriglio , et al. January 30, 2	2018-01-30
Pyrazolopyridyl compounds as aldosterone synthase inhibitors Grant 9,844,553 - Bennett , et al. December 19, 2	2017-12-19
Isoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 Grant 9,828,369 - Imbriglio , et al. November 28, 2	2017-11-28
Isoquinoline Derivatives Useful As Inhibitors Of Diacylglyceride O-acyltransferase 2 App 20170275274 - Imbriglio; Jason ; et al.	2017-09-28
Tetrahydroisoquinoline Derivatives Useful As Inhibitors Of Diacylglyceride O-acyltransferase 2 App 20170273965 - Imbriglio; Jason ; et al.	2017-09-28
Tetrahydroisoquinoline Derivatives Useful As Inhibitors Of Diacylglyceride O-acyltransferase 2 App 20170273966 - Imbriglio; Jason ; et al.	2017-09-28
Substituted spiropiperidinyl compounds useful as GPR120 agonists Grant 9,708,270 - Chelliah , et al. July 18, 2	2017-07-18
Metallo-beta-lactamase inhibitors Grant 9,708,336 - Mandal , et al. July 18, 2	2017-07-18
Triazolopyridyl compounds as aldosterone synthase inhibitors Grant 9,567,333 - Bennett , et al. February 14, 2	2017-02-14
Pyrazolopyridyl Compounds As Aldosterone Synthase Inhibitors App 20170020879 - Bennett; D. Jonathan ; et al.	2017-01-26
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C Grant 9,549,921 - He , et al. January 24, 2	2017-01-24
Indazole compounds as aldosterone synthase inhibitors Grant 9,522,141 - Hoyt , et al. December 20, 2	2016-12-20
Imidazopyridyl compounds as aldosterone synthase inhibitors Grant 9,518,055 - Ali , et al. December 13, 2	2016-12-13
Metallo-beta-lactamase Inhibitors App 20160333021 - Mandal; Mihir ; et al.	2016-11-17
Aldosterone synthase inhibitors Grant 9,382,226 - Hoyt , et al. July 5, 2	2016-07-05
Pyrazolopyridyl compounds as aldosterone synthase inhibitors Grant 9,351,973 - Bennett , et al. May 31, 2	2016-05-31
Heterocyclic Compounds And Methods Of Use Thereof For The Treatment Of Hepatitis C App 20160143895 - He; Shuwen ; et al.	2016-05-26
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases Grant 9,265,773 - McComas , et al. February 23, 2	2016-02-23
Triazolopyridyl Compounds As Aldosterone Synthase Inhibitors App 20160039817 - Bennett; D. Jonathan ; et al.	2016-02-11
Imidazopyridyl Compounds As Aldosterone Synthase Inhibitors App 20160031882 - Ali; Amjad ; et al.	2016-02-04
Triazolopyridyl compounds as aldosterone synthase inhibitors Grant 9,193,724 - Bennett , et al. November 24, 2	2015-11-24
Indazole Compounds As Aldosterone Synthase Inhibitors App 20150320733 - Hoyt; Scott B. ; et al.	2015-11-12
Substituted Spiropiperidinyl Compounds Useful As Gpr120 Agonists App 20150274672 - Chelliah; Mariappan ; et al.	2015-10-01
Aldosterone synthase inhibitors Grant 9,073,929 - Hoyt , et al. July 7, 2	2015-07-07
Pyrazolopyridyl Compounds As Aldosterone Synthase Inhibitors App 20140288094 - Bennett; D. Jonathan ; et al.	2014-09-25
Triazolopyridyl Compounds As Aldosterone Synthase Inhibitors App 20140228396 - Bennett; D. Jonathan ; et al.	2014-08-14
Tetracyclic Heterocycle Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20140213571 - Liverton; Nigel J. ; et al.	2014-07-31
Aldosterone Synthase Inhibitors App 20140045819 - Hoyt; Scott B. ; et al.	2014-02-13
Aldosterone Synthase Inhibitors App 20130317057 - Hoyt; Scott B. ; et al.	2013-11-28
N-substituted oxindoline derivatives as calcium channel blockers Grant 8,273,749 - Duffy , et al. September 25, 2	2012-09-25
Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers App 20110136842 - Duffy; Joseph L. ; et al.	2011-06-09
Benzaepinones as sodium channel blockers Grant 7,888,345 - Hoyt , et al. February 15, 2	2011-02-15
N-substituted Oxindoline Derivatives As Calcium Channel Blockers App 20100216815 - Duffy; Joseph L. ; et al.	2010-08-26
N-substituted Oxindoline Derivatives As Calcium Channel Blockers App 20100204247 - Duffy; Joseph L. ; et al.	2010-08-12
Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers App 20100144715 - Hoyt; Scott B. ; et al.	2010-06-10
Benzaepinones as Sodium Channel Blockers App 20090181946 - Hoyt; Scott B. ; et al.	2009-07-16
Sulfone derivatives as 5-HT7 receptor ligands Grant 7,101,892 - Bourrain , et al. September 5, 2	2006-09-05
Sulfone derivatives as 5-HT7 receptor ligands App 20040229864 - Bourrain, Sylvie ; et al.	2004-11-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.